Related Experiment Video

Updated: Aug 30, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Liver biopsy size matters in chronic hepatitis: bigger is better

Peter J Scheuer

    Hepatology (Baltimore, Md.)
    |December 4, 2003
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
    04:14

    Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

    Published on: April 16, 2019

    Extended 78% Hepatectomy in a Mouse Surgical Model
    05:25

    Extended 78% Hepatectomy in a Mouse Surgical Model

    Published on: May 24, 2024

    Related Experiment Videos

    Last Updated: Aug 30, 2026

    Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
    07:10

    Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

    Published on: June 18, 2020

    Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
    04:14

    Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

    Published on: April 16, 2019

    Extended 78% Hepatectomy in a Mouse Surgical Model
    05:25

    Extended 78% Hepatectomy in a Mouse Surgical Model

    Published on: May 24, 2024

    Related Concept Videos

    Cirrhosis I: Introduction01:23

    Cirrhosis I: Introduction

    Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.

    Hepatology (Baltimore, Md.)·2004

    Scoring of chronic hepatitis.

    Clinics in liver disease·2002

    Beyond cirrhosis: Major adverse liver outcomes across homozygous and heterozygous Alpha-1 antitrypsin deficiency associated liver disease.

    Hepatology (Baltimore, Md.)·2026

    Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4-based two-step algorithms for MASLD.

    Hepatology (Baltimore, Md.)·2026

    A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.

    Hepatology (Baltimore, Md.)·2026

    Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.

    Hepatology (Baltimore, Md.)·2026

    Liver-on-a-Chip: Applications for clinical modeling of liver disease using microscale systems.

    Hepatology (Baltimore, Md.)·2026

    BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.

    Hepatology (Baltimore, Md.)·2026

    PUM1 Promotes HCC Cell Proliferation and Inhibits Mitochondria‑mediated Apoptosis, Accompanied by Activation of the PI3K-AKT Pathway.

    Journal of hepatocellular carcinoma·2026

    Breaking the antimicrobial resistance dilemma: marine natural products, a treasure trove for the development of new anti-Staphylococcus aureus drugs.

    Marine life science & technology·2026

    Optimizing plasma-derived small extracellular vesicle purification to enhance downstream applications.

    iScience·2026

    Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems.

    International journal of pharmaceutics: X·2026

    N-Terminal polarity reversal of cysteine-terminated peptides: A strategy to develop potent metallo-β-lactamase inhibitors with in vivo efficacy.

    European journal of medicinal chemistry·2026

    Non-Oncology Biomarkers in Precision Medicine: A Narrative Review.

    Therapeutic innovation & regulatory science·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us